FindTrial
Sign In

The effect of oral intake of sulforaphane glucosinolate on the maintenance and improvement of cognitive function -A systematic review with meta-analysis

The effect of oral intake of sulforaphane glucosinolate on the maintenance and improvement of cognitive function -A systematic review with meta-analysis - The effect of sulforaphane glucosinolate on cognitive function -A systematic review with meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000047404
Enrollment
Unknown
Registered
2024-03-31
Start date
2022-04-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

None listed

Sponsors

KAGOME CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (PICO) Participant: Healthy adults without illness (excluding pregnant women (including those planning to become pregnant) and lactating women) Intervention: Oral intake of foods containing SGS (regardless of the form of intake) Comparison: Oral intake of placebo foods that do not contain SGS, or no intervention Outcome: Maintenance and improvement of cognitive function Study design: Randomized controlled parallel trials (RCT-P), randomized controlled crossover trials (RCT-C), quasi- randomized controlled parallel trials (qRCT-P), quasi randomized controlled crossover trials (qRCT-C), non-randomized controlled parallel trials (nonRCT-P), non-randomized controlled crossover trials (nonRCT-C), and non-randomized controlled trials (Language) Eligibility is not restricted by language.

Exclusion criteria

Exclusion criteria: Proceedings and unpublished studies which don't give us enough research details, and other gray documents that are difficult to verify will be excluded.

Design outcomes

Primary

MeasureTime frame
Cognitive function—

Countries

Japan

Contacts

Public ContactShingo Takahashi

KAGOME CO., LTD. Innovation Division

g167_0@kagome.co.jp0287-36-2935

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026